Erbitux approved for metastatic colon cancer treatment in Europe


(Reuters) - Erbitux is now approved to treat patients with RAS wild-type metastatic colorectal cancer by the European Commission.

The European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, had recommended the approval in late November.


Source: Reuters:

No Comment